Article
Bethesda, Md. - Replacing a patient's immune system with cancer-fighting cells can lead to the shrinkage of advanced melanoma tumors, researchers from the National Cancer Institute reported.
Developing an OTC Dermatology Product
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Optimizing Care for Patients with Urticaria
Denise Dajles, DEng, MSc, Ushers in a New Era at Cytrellis Biosystems, Looks to Future of Aesthetics Industry